New Zealand Companies Out of the 'Chillybin'
Client Alert | less than 1 min read | 08.19.15
On August 12, the U.S. in a Federal Register notice confirmed that it "has agreed to waive discriminatory purchasing requirements for eligible products and suppliers of New Zealand beginning on August 12, 2015," due to the WTO's approval of New Zealand as a member of the WTO Agreement on Government Procurement (GPA). Joining the 43-member GPA will provide new access to the U.S. federal marketplace for New Zealand-based companies, including "designated country" status under the Trade Agreements Act, and will open immediate doors to federal government contracting opportunities, including GSA and VA Schedule contracts, that generally limit acquisition to end products that are manufactured or substantially transformed in the U.S. or a "designated country."
Contacts
Insights
Client Alert | 7 min read | 06.26.26
Federal Roundup: Updates for PBMs and Medicare Advantage Organizations
In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future.
Client Alert | 6 min read | 06.26.26
Client Alert | 4 min read | 06.25.26
Twin Executive Orders Seek to Spur Quantum Leap in Technology and Cybersecurity
Client Alert | 7 min read | 06.24.26
